Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS) | © Tada Images - stock.adobe.com (521699065)

What to Know from the FDA’s End of August Activity

ByZachary Zubulake

August 28th 2026

PharmTech Weekly Roundup—August 28, 2026

BySusan Haigney

August 28th 2026

Pharma Fundamentals: Risks and Regulations for Hold Times in Biopharmaceuticals

ByRobert Dream,Susan Haigney

August 27th 2026

Pharma's Next AI Problem Is Authority

ByBrian Drapeau

August 27th 2026

FDA-approved RASONQUE (daraxonrasib) tablets mark the first broad RAS-targeted therapy for metastatic pancreatic cancer treatment.

Rasonque's 60% Survival Benefit: What It Means for Oncology Pipelines

ByZachary Zubulake

August 26th 2026

Emerging Analytical Technology: Moving from the Lab to the Line

Articles in this issue

Related Content

What to Know from the FDA’s End of August Activity

PharmTech Weekly Roundup—August 28, 2026

Pharma Fundamentals: Risks and Regulations for Hold Times in Biopharmaceuticals

Pharma's Next AI Problem Is Authority

Rasonque's 60% Survival Benefit: What It Means for Oncology Pipelines

Trending on Pharmaceutical Technology

What to Know from the FDA’s End of August Activity

Pharma's Next AI Problem Is Authority

Rasonque's 60% Survival Benefit: What It Means for Oncology Pipelines

Rethinking the Path from Spray-Dried Dispersions to Tablets: The Role of Continuous Direct Compression

Can Predictive Modelling Fix Fragmented Pharma Development Data?